CLAIM CARD
The evidence base for coenzyme Q10 (CoQ10) supplementation and immune/inflammatory outcomes spans multiple study designs, including clinical RCTs in specific patient populations, observational cohorts, and several systematic reviews and meta-analyses. In a randomized, placebo-controlled trial in hepatocellular carcinoma patients after surgery, Liu 2016 investigated CoQ10 supplementation's effects on oxidative stress and inflammation, with mixed results across multiple measured endpoints. The umbrella meta-analysis by Varnousfaderani 2023 synthesized data across studies to evaluate CoQ10's effects on biomarkers of inflammation and oxidative stress in adults. Additional systematic reviews by Zhai 2017, Jorat 2019, Alimohammadi 2021, and Xu 2022 examined various inflammatory markers in coronary artery disease, breast cancer, and chronic kidney disease populations.
Evidence grade: exploratory
Contradiction status: none
Publication: b8dee5f7-0023-4af5-bacc-446de915555a
Provenance: Derivation Web chain
Citation Support
source_1Xu 2024source_2Spiegeleer 2025source_3Shang 2024source_4Alehagen 2020source_5Phan 2020